DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
 5,520.00
 -40.00 (-0.72%)
  At close: Oct 28, 2025
DongKoo Bio & Pharma Revenue
DongKoo Bio & Pharma had revenue of 60.12B KRW in the quarter ending June 30, 2025, a decrease of -1.94%. This brings the company's revenue in the last twelve months to 242.55B, up 0.90% year-over-year. In the year 2024, DongKoo Bio & Pharma had annual revenue of 249.27B with 15.57% growth.
Revenue (ttm) 
 242.55B
Revenue Growth 
 +0.90%
P/S Ratio 
 0.60
Revenue / Employee 
 600.38M
Employees 
 404
Market Cap 
144.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 249.27B | 33.59B | 15.57% | 
| Dec 31, 2023 | 215.69B | 20.70B | 10.62% | 
| Dec 31, 2022 | 194.99B | 39.84B | 25.68% | 
| Dec 31, 2021 | 155.15B | 15.93B | 11.45% | 
| Dec 31, 2020 | 139.22B | 38.09B | 37.67% | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Samsung Electronics | 308.59T | 
| Hyundai Motor Company | 182.25T | 
| Kia Corporation | 111.04T | 
| SK hynix | 77.21T | 
| LG Energy Solution | 25.16T | 
| Hanwha Aerospace | 19.25T | 
| Doosan Enerbility | 16.30T | 
| HD Hyundai Heavy Industries | 15.58T |